支氣管鏡下切片設備的全球市場:規模，佔有率，COVID-19影響分析(2023年～2029年):MedCore

全球支氣管鏡下切片設備的市場規模在2022年估算為1億3,480萬美金。該市場在預測期間內預計將以9.0％的年複合成長率擴大，並達到2億4,710萬美元。

本報告提供全球支氣管鏡下切片設備市場相關調查，提供市場概要，以及各市場區隔，各地區趨勢，競爭情形等資訊。

目錄

支氣管鏡下切片設備市場

• 簡介
• 市場概要
• 市場分析與預測
  • 支氣管鉗市場全體
  • 經支氣管細針抽吸市場全體
• 促進因素與阻礙因素
  • 推動市場要素
  • 阻礙市場要素
• 競爭市場佔有率分析

The global market for bronchoscopic biopsy devices was valued at $134.8 million in 2022, with an anticipated increase to $247.1 million at a CAGR of 9.0% during the forecast period. The complete report suite on this market encompasses bronchial forceps and transbronchial needle aspiration (TBNA) needle devices as its segments.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2029, and Historical Data to 2019

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

GLOBAL BRONCHOSCOPIC BIOPSY DEVICE MARKET INSIGHTS

A main market driver in the TBNA market is innovation. The newly established products are on the higher end of the price range that will drive up the market growth.

GLOBAL BRONCHOSCOPIC BIOPSY DEVICE MARKET SHARE INSIGHTS

The Global bronchoscopic biopsy device market was led by Olympus, Boston Scientific, and Cook Medical.

In 2022, Olympus emerged as the top competitor in the bronchoscopic biopsy device market, holding a significant market share. The company had a presence in both the disposable bronchial forceps and TBNA markets. Olympus was the leading player in the endobronchial ultrasound (EBUS)-TBNA market, with a major share of the market. Its ViziShot® product line, which has been available in the market for more than ten years, features an extensive range of TBNA needles.

MARKET SEGMENTATION SUMMARY

Bronchoscopic Biopsy Device Market - MedCore - Includes:

• Segments of bronchial forceps and transbronchial needle aspiration (TBNA) needle devices.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Table of Contents

Bronchoscopic Biopsy Device Market

• 18.1 Introduction
• 18.2 Market Overview
• 18.3 Market Analysis and Forecast
  • 18.3.1 Total Bronchial Forceps Market
    • 18.3.1.1 Disposable Bronchial Forceps Market
    • 18.3.1.2 Reusable Bronchial Forceps Market
  • 18.3.2 Total Transbronchial Aspiration Needle Market
    • 18.3.2.1 Conventional TBNA Market
    • 18.3.2.2 EBUS-TBNA Market
• 18.4 Drivers and Limiters
  • 18.4.1 Market Drivers
  • 18.4.2 Market Limiters
• 18.5 Competitive Market Share Analysis

LIST OF CHARTS

• Chart 18-1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 - 2029
• Chart 18-2: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022

LIST OF FIGURES

• Figure 18-1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 - 2029 (US$M)
• Figure 18-2: Bronchial Forceps Market by Type, U.S., 2019 - 2029 (US$M)
• Figure 18-3: Total Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-4: Disposable Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-5: Reusable Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-6: Transbronchial Aspiration Needle Market by Type, U.S., 2019 - 2029 (US$M)
• Figure 18-7: Total Transbronchial Aspiration Needle Market, U.S., 2019 - 2029
• Figure 18-8: Conventional TBNA Market, U.S., 2019 - 2029
• Figure 18-9: EBUS-TBNA Market, U.S., 2019 - 2029
• Figure 18-10: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022